CareLit · DOI-Nachweis · Klinische Pädiatrie
Subsequent Malignant Neoplasms in Survivors of Pediatric DAL/GPOH-Hodgkin-Lymphoma Trials
DOI 10.1055/s-0034-1371161
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Dörffel, M Riepenhausen, H Lüders, J Brämswig, G Schellong
ZeitschriftKlinische Pädiatrie
Ausgabe03/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Question: Subsequent malignant neoplasms (SMN) represent one of the most serious late effects following treatment of pediatric Hodgkin lymphoma (HL). Their evaluation is essential for final assessment of therapy optimization trials. Methods: 2548 patients from Germany, Austria and Switzerland were treated in 7 consecutive DAL/GPOH-HL trials between 1978 and 2002, the majority with combined modality treatment includi…
Zitieren
Zitierempfehlung
W Dörffel, M Riepenhausen, H Lüders, J Brämswig, G Schellong (2014) Subsequent Malignant Neoplasms in Survivors of Pediatric DAL/GPOH-Hodgkin-Lymphoma Trials. Klinische Pädiatrie (03). https://doi.org/10.1055/s-0034-1371161
Mit CareLit weiterarbeiten